Superworth

Beta Bionics EPS BBNX

Diluted earnings per share by quarter and over the last twelve months, from 2024.

Last 12 months, to Sep 30, 2026
−$1.84
Latest quarter, Q3 FY26
−$0.52
Fiscal year 2025
−$1.95

Beta Bionics' earnings per share was −$1.84 over the twelve months to Sep 30, 2026.

In its latest quarter, Q3 FY26, it was −$0.52.

Earnings per share over time

Open the interactive chart, with overlays and comparisons

Fiscal year by fiscal year

Fiscal yearEPSChange
FY2025−$1.95n/a
FY2024−$8.62n/a

Each fiscal year is the twelve months to its fourth quarter.

Quarter by quarter

QuarterEndedEPSOn a year earlierLast 12 months
Q3 FY26−$0.52n/a−$1.84
Q2 FY26−$0.53n/a−$1.65
Q1 FY26−$0.49n/a−$1.51
Q4 FY25−$0.30n/a−$1.95
Q3 FY25−$0.33n/a−$4.37
Q2 FY25−$0.39n/a−$5.50
Q1 FY25−$0.93n/a−$7.48
Q4 FY24−$2.72n/a−$8.62
Q3 FY24−$1.46n/an/a
Q2 FY24−$2.37n/an/a
Q1 FY24−$2.07n/an/a

Against its peers

Companies in Medical - Instruments & Supplies nearest Beta Bionics' size, closest first, today.

CompanyEPS, 12 monthsGrowth
BBNXBeta Bionics−$1.84
IRMDIradimed$1.87+13% a year
MOVMovado$1.80+137% a year
IARTIntegra Lifesciences$0.17
BVSBioventus$0.77+627% a year
STAAStaar Surgical$0.07
CDRECadre$0.81−14% a year
EYENational Vision$0.61
TCMDTactile Systems Technology$1.08+74% a year
LMATLemaitre Vascular$2.85+38% a year
INSPInspire Medical Systems$4.62+132% a year
Peer median$0.94

What the EPS figure tells you

Net income divided by diluted shares. The denominator of PE.

One-off charges and gains swing it. The TTM view smooths a single odd quarter.

More on Beta Bionics

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.